Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
This list highlights altcoins with clear real-world use cases and tangible value, helping readers prioritize projects with practical impact.
24,805 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
As miners shift capital from BTC holdings to AI compute, the landscape for there bitcoin mining stocks changes. This ...
When prominent athletes face controversy, the financial implications go beyond contracts. This piece explores how Adr...
Meta wants cloud could shake up the cloud market and test Amazon's AWS dominance. This guide breaks down what that co...
Thousands are flocking North Carolina’s cities, drawn by opportunity, growing tech jobs, and affordable housing. This...
A clear, investor-friendly look at Sonida's Q1 2026 performance. We unpack the numbers, the drivers behind them, and ...
A major settlement shines a light on insulin pen refill practices in government health programs. This article explain...
A sizable $12 million stake in a floor-and-decor retailer arrives as the stock trades off. This article breaks down t...
Explore how SM Energy navigated Q1 2026, what the earnings transcript reveals about cash flow, production, and capita...
High-profile legal battles hit more than headlines—they hit your wallet. Discover how the stefon diggs legal fight hi...
A jury finds elon musk liable for misleading investors during Twitter's $44 billion takeover, signaling a landmark ru...
SpaceX aims for a $1.75 trillion IPO, triggering a fierce debate among analysts about whether growth, cash flow, and ...